With industry dominating large-scale compute, academia's function is no longer to train the biggest models. Instead, its value lies in pursuing unconventional, high-risk research in areas like new algorithms, architectures, and theoretical underpinnings that commercial labs, focused on scaling, might overlook.

According to a partner at Radical Ventures, the frontier for AI startups is expanding beyond software ('bits') into the physical world ('atoms'). The next wave of high-impact AI companies will tackle complex challenges in sectors like energy, critical minerals, and manufacturing.

The focus on AI automating existing human labor misses the larger opportunity. The most significant value will come from creating entirely new types of companies that are fully autonomous and operate in ways we can't currently conceive, moving beyond simple replacement of today's jobs.

Current AI pricing models, which pass on expensive LLM costs to users, are temporary. As LLM costs inevitably collapse and become commoditized, the winning companies will be those who have already evolved their monetization to be based on the value their product delivers.

The internet leveled the playing field by making information accessible. AI will do the same for intelligence, making expertise a commodity. The new human differentiator will be the creativity and ability to define and solve novel, previously un-articulable problems.

While AI-driven efficiency is valuable, Mistral's CEO argues the technology's most profound impact will be accelerating fundamental R&D. By helping overcome physical constraints in fields like semiconductor manufacturing or nuclear fusion, AI unlocks entirely new technological progress and growth—a far greater prize than simple process optimization.

AI isn't just an incremental improvement; it's a reinvention of the computer. This new paradigm makes previously intractable problems—from curing cancer to eliminating fraud—solvable. This opens up an unprecedented wave of entrepreneurial opportunity to rebuild everything.

The combination of AI's reasoning ability and cloud-accessible autonomous labs will remove the physical barriers to scientific experimentation. Just as AWS enabled millions to become programmers without owning servers, this new paradigm will empower millions of 'citizen scientists' to pursue their own research ideas.

Bob Nelsen believes the industry overestimates AI's short-term impact and underestimates its long-term potential. He predicts that once a critical data threshold is met, AI models won't just accelerate drug discovery but will fundamentally invent new biology, creating a sudden, paradigm-shifting moment.